SignaCor Therapeutics
SignaCor Therapeutics
Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health.
About
What does SignaCor Therapeutics do?
SignaCor Therapeutics is a clinical-stage drug development company spun out from Queen's University Belfast. They are developing first-in-class therapies for symptomatic hypertrophic cardiomyopathy (HCM) that target underlying disease pathology to reverse heart damage and improve patient outcomes.
What is SignaCor Therapeutics's revenue?
StartupHub estimates SignaCor Therapeutics's annual revenue at $48K (range $21K to $154K, 32% confidence), based on comparable companies in the sector.
What is SignaCor Therapeutics's valuation?
StartupHub estimates SignaCor Therapeutics's effective valuation at $1.2M (range $788K to $1.9M, 22% confidence), based on comparable companies in the sector.
How much funding has SignaCor Therapeutics raised?
SignaCor Therapeutics has raised a total of $315K in funding. The most recent round on record is Seed.
Where is SignaCor Therapeutics headquartered?
SignaCor Therapeutics is headquartered in Belfast, United Kingdom.
When was SignaCor Therapeutics founded?
SignaCor Therapeutics was founded in 2024.
What industry does SignaCor Therapeutics operate in?
SignaCor Therapeutics operates in HealthTech, Biotechnology, Cardiovascular Health, Cardiovascular.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.